Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol in Rodent Models of Parkinson’s Disease: A Systematic Review of Experimental Studies
Cheng-Fu Su, Jiang Li, Xiaowen Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Transgenerational hormesis in healthy aging and antiaging medicine from bench to clinics: Role of food components
Vittorio Calabrese, Naomi Osakabe, Rosalba Siracusa, et al.
Mechanisms of Ageing and Development (2024) Vol. 220, pp. 111960-111960
Closed Access | Times Cited: 2
The Potential Role of miRNA-Regulated Autophagy in Alzheimer’s Disease
Hu Zhang, Jiling Liang, Ning Chen
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7789-7789
Open Access | Times Cited: 13
Dysregulation of miR‐543 in Parkinson's disease: Impact on the neuroprotective gene SIRT1
Mirte Scheper, Anand M. Iyer, Jasper J. Anink, et al.
Neuropathology and Applied Neurobiology (2022) Vol. 49, Iss. 1
Open Access | Times Cited: 13
Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
Irene Sanchez-Mirasierra, Saurav Ghimire, Sergio Hernández-Díaz, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
Mechanistic Insights into Polyphenols’ Aggregation Inhibition of α-Synuclein and Related Peptides
Gabriel F. Martins, Cairo Lúcio Nascimento, Nuno Galamba
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 10, pp. 1905-1920
Open Access | Times Cited: 7
Neuroprotection of resveratrol against cadmium-poisoning acts through dual inhibition of mTORC1/2 signaling
Chunxiao Liu, Ruijie Zhang, Yang Liu, et al.
Neuropharmacology (2022) Vol. 219, pp. 109236-109236
Open Access | Times Cited: 11
CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
Andrea Baier, Ryszard Szyszka
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 9
Shisandra Decoction Alleviates Parkinson’s Disease Symptoms in a Mouse Model Through PI3K/AKT/mTOR Signalling Pathway
Yawen Pan, Mojinzi Chen, Lulu Pan, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2011-2027
Open Access | Times Cited: 1
Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological Diseases
Biswajit Kumar Utpal, Fatima Zohra Mokhfi, Mehrukh Zehravi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1
Resveratrol and Curcumin for Chagas Disease Treatment—A Systematic Review
Carlos Henrique Lima Imperador, Cauê Benito Scarim, Priscila Longhin Bosquesi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 609-609
Open Access | Times Cited: 8
Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease
Meng-Fan Yao, Tao Dang, Huajun Wang, et al.
Behavioural Brain Research (2023) Vol. 459, pp. 114811-114811
Open Access | Times Cited: 4
Interaction of Medicinal Plants and Their Active Constituents With Potassium Ion Channels: A Systematic Review
Arezoo Rajabian, Fatemeh Rajabian, Fatemeh Babaei, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Neuropharmaceutical Properties of Naringin Against Alzheimer's and Parkinson's Diseases
Sahar Poudineh, Maryam Poudineh, Tahere Ghotbi, et al.
Galen Medical Journal (2022) Vol. 11
Open Access | Times Cited: 7
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Review of Pre-clinical Studies
Samay Prakash, Wayne G. Carter
(2021)
Open Access | Times Cited: 9
Epigallocatechin-3-gallate and resveratrol attenuate hydrogen peroxide induced damage in neuronal cells
Meltem Yılmaz Cosar, Mümin Alper Erdoğan, Özlem Yılmaz
Bratislavské lekárske listy/Bratislava medical journal (2023) Vol. 124, Iss. 03, pp. 205-211
Open Access | Times Cited: 3
An Automated Cell Detection Method for TH-positive Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease Using Convolutional Neural Networks
Doyun Kim, Myeong Seong Bak, Haney Park, et al.
Experimental Neurobiology (2023) Vol. 32, Iss. 3, pp. 181-194
Open Access | Times Cited: 3
A critical analysis on the concentrations of phenolic compounds tested using in vitro and in vivo Parkinson’s disease models
José Messias Perdigão, Bruno José Brito Teixeira, Vinicius Carvalho-da-Silva, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 64, Iss. 19, pp. 6596-6615
Open Access | Times Cited: 2
Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
Nicola Paccione, Mahdieh Rahmani, Emilia Barcia, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 13-13
Open Access | Times Cited: 4
Nutraceuticals in the management of Parkinson’s disease and dementia
Devesh U. Kapoor, Deepak Sharma, J.B. Sharma, et al.
Elsevier eBooks (2024), pp. 441-466
Closed Access
[Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axis
Jiawei Gui, Xiaoguang Sun, Shenglin Wen, et al.
PubMed (2024) Vol. 44, Iss. 2, pp. 270-279
Closed Access
Mitochondrial Dysfunction as a Potential Mechanism Mediating Cardiac Comorbidities in Parkinson’s Disease
Alberto Torres, Jieun Lee, Andrea Caporali, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10973-10973
Open Access
Injectable Hierarchical Bioactive Hydrogels with Fibroblast Growth Factor 21/Edaravone/Caffeic Acid Asynchronous Delivery for Treating Parkinson's Disease
Junpeng Xu, Peng Dai, Chen Zhang, et al.
Advanced Science (2024)
Closed Access
Evaluation of Nanomaterials as Effective Carriers Targeted to Traverse Blood–Brain Barrier for Theragnostics of Neurodegenerative Diseases: An Overview
D. Vengadesan, Natarajan Arumugam, E. Manikandan, et al.
BioNanoScience (2024) Vol. 15, Iss. 1
Closed Access
Suppression of porcine hemagglutinating encephalomyelitis virus replication by resveratrol
Yuzhu Liu, Deguang Song, Xueli Liu, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism
José Ivo Araújo Beserra‐Filho, Amanda Maria‐Macêdo, Suellen Silva‐Martins, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 7, pp. 2331-2347
Closed Access | Times Cited: 2

Scroll to top